Radius Health Announces Third Quarter 2018 Operating Results and Financial Guidance for FY 2018 and FY 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Radius Health (RDUS) Tops Q3 EPS by 19c, Revenues Beat; Offers FY18 Revenue Views Above Consensus, Offers FY19 Revenue Outlook
November 1, 2018 7:42 AM EDTRadius Health (NASDAQ: RDUS) reported Q3 EPS of ($1.09), $0.19 better than the analyst estimate of ($1.28). Revenue for the quarter came in at $27.6 million versus the consensus estimate of $25.42 million.
I am very pleased with the continued strong trajectory of our launch and success in... More
